PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
29.44%
Revenue growth exceeding 1.5x VET's 5.59%. David Dodd would verify if faster growth reflects superior business model.
29.10%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
29.73%
Gross profit growth exceeding 1.5x VET's 7.45%. David Dodd would verify competitive advantages.
0.23%
Margin expansion below 50% of VET's 1.76%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.84%
Other expenses change of 5.84% while VET maintains costs. Bruce Berkowitz would investigate efficiency.
3.43%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
19.12%
Total costs growth while VET reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
5.84%
D&A growth while VET reduces D&A. John Neff would investigate differences.
35.49%
EBITDA growth exceeding 1.5x VET's 6.63%. David Dodd would verify competitive advantages.
-5.00%
EBITDA margin decline while VET shows 36.37% growth. Joel Greenblatt would examine position.
53.71%
Operating income growth exceeding 1.5x VET's 14.37%. David Dodd would verify competitive advantages.
18.75%
Operating margin growth exceeding 1.5x VET's 8.32%. David Dodd would verify competitive advantages.
212.00%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
134.86%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
81.45%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
99.09%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
206.43%
Net income growth while VET declines. John Neff would investigate advantages.
136.74%
Net margin growth while VET declines. John Neff would investigate advantages.
285.71%
EPS growth while VET declines. John Neff would investigate advantages.
280.22%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-6.66%
Share count reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.
-5.30%
Diluted share reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.